We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+0.94%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$253M
AUM Growth
-$2.04B
Cap. Flow
-$2.04B
Cap. Flow %
-806.85%
Top 10 Hldgs %
100%
Holding
2,307
New
Increased
Reduced
6
Closed
2,297

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$126M
2
AAPL icon
Apple
AAPL
+$100M
3
NVDA icon
NVIDIA
NVDA
+$90M
4
AMZN icon
Amazon
AMZN
+$66.5M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$43.9M

Sector Composition

Rank Sector Weight
1 Communication Services 0%
2 Consumer Discretionary 0%
3 Consumer Staples 0%
4 Energy 0%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VNDA icon
2051
Vanda Pharmaceuticals
VNDA
$305M
-1,471
Closed -$6.05K
VNO icon
2052
Vornado Realty Trust
VNO
$7.42B
-4,936
Closed -$142K
VPG icon
2053
Vishay Precision Group
VPG
$930M
-629
Closed -$22.2K
VRA icon
2054
Vera Bradley
VRA
$94.7M
-438
Closed -$2.98K
VRDN icon
2055
Viridian Therapeutics
VRDN
$2.52B
-2,632
Closed -$46.1K
VRE
2056
DELISTED
Veris Residential
VRE
-6,678
Closed -$102K
VREX icon
2057
Varex Imaging
VREX
$780M
-2,356
Closed -$42.6K
VRNS icon
2058
Varonis Systems
VRNS
$5.01B
-5,712
Closed -$269K
VRNT
2059
DELISTED
Verint Systems
VRNT
-3,224
Closed -$107K
VRRM icon
2060
Verra Mobility
VRRM
$714M
-7,188
Closed -$179K
VRSK icon
2061
Verisk Analytics
VRSK
$23.6B
-5,848
Closed -$1.38M
VRSN icon
2062
VeriSign
VRSN
$25.7B
-3,554
Closed -$674K
VRTX icon
2063
Vertex Pharmaceuticals
VRTX
$132B
-10,394
Closed -$4.34M
VRTS icon
2064
Virtus Investment Partners
VRTS
$1.12B
-367
Closed -$91K
VSEC icon
2065
VSE Corp
VSEC
$6.69B
-743
Closed -$59.4K
VSH icon
2066
Vishay Intertechnology
VSH
$5.21B
-6,691
Closed -$152K
VTLE
2067
DELISTED
Vital Energy
VTLE
-1,327
Closed -$69.7K
VTOL icon
2068
Bristow Group
VTOL
$1.36B
-1,252
Closed -$34.1K
VTR icon
2069
Ventas
VTR
$46.2B
-28,653
Closed -$1.25M
VTRS icon
2070
Viatris
VTRS
$18.7B
-48,386
Closed -$578K
VTS icon
2071
Vitesse Energy
VTS
$677M
-1,372
Closed -$32.6K
VTYX
2072
DELISTED
Ventyx Biosciences
VTYX
-2,579
Closed -$14.2K
VVX icon
2073
V2X
VVX
$2.53B
-573
Closed -$26.8K
VWO icon
2074
Vanguard FTSE Emerging Markets ETF
VWO
$126B
-90,640
Closed -$3.79M
VYGR icon
2075
Voyager Therapeutics
VYGR
$202M
-1,743
Closed -$16.2K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q2 2024 Portfolio in Review

As of Q2 2024, Metropolitan Life Insurance Company (MetLife) held 2,307 positions worth $253M, down 89% from $2.3B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Metropolitan Life Insurance Company (MetLife) withdrew a net $2.04B in Q2 2024, closing 2,297 positions and reducing 6 holdings. Its most notable exit was Microsoft, an estimated $126M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 0% of assets, down from 7.1% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $43.9M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Microsoft in Q2 2024, selling an estimated $126M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 100% of its $253M portfolio in Q2 2024.
  • Metropolitan Life Insurance Company (MetLife) opened 0 new positions and closed 2,297 in Q2 2024.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 89% quarter-over-quarter to $253M.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.